Podcast synopsis of updates to the European Renal Best Practice and UK Kidney Association guidelines for treatment of anemia in chronic kidney disease
- 23-09-2025
- Chronic Kidney Disease
- Podcast
University of Milan and ASST Santi Paolo and Carlo Hospitals, Milan, Italy
Queen Elizabeth University Hospital, Glasgow, UK
Hull York Medical School, York, UK, and Hull University Teaching Hospitals NHS Trust, Hull, UK
This podcast offers a clinical overview of recent updates to the European Renal Best Practice (ERBP) and UK Kidney Association (UKKA) guidelines for the treatment of anemia associated with chronic kidney disease (CKD). It focuses on the role of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) as an alternative to erythropoiesis-stimulating agents (ESAs) for the treatment of anemia of CKD. The discussion encompasses efficacy, safety, and prescribing considerations for specific patient groups, including those with inflammation, a cardiovascular history, or a history of kidney transplants. The podcast aims to support clinicians in making informed, individualized treatment decisions based on the latest evidence and guideline recommendations.